BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14613000)

  • 21. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
    Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
    Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours.
    Dahmane N; Lee J; Robins P; Heller P; Ruiz i Altaba A
    Nature; 1997 Oct; 389(6653):876-81. PubMed ID: 9349822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene linked to commonest cancer.
    Pennisi E
    Science; 1996 Jun; 272(5268):1583-4. PubMed ID: 8658128
    [No Abstract]   [Full Text] [Related]  

  • 24. Towards a unified model of tumor suppression: lessons learned from the human patched gene.
    Dean M
    Biochim Biophys Acta; 1997 Apr; 1332(2):M43-52. PubMed ID: 9141460
    [No Abstract]   [Full Text] [Related]  

  • 25. Allele loss on chromosome 9q22.2-22.3 in sporadic basal cell carcinoma in Chinese.
    He C; Zhang X; Wang Y; Sun K; Chen HD
    Chin Med J (Engl); 1999 Jun; 112(6):497-500. PubMed ID: 11601325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
    Cairns P; Shaw ME; Knowles MA
    Oncogene; 1993 Apr; 8(4):1083-5. PubMed ID: 8096074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated induction of bladder cancer in patched heterozygous mutant mice.
    Hamed S; LaRue H; Hovington H; Girard J; Jeannotte L; Latulippe E; Fradet Y
    Cancer Res; 2004 Mar; 64(6):1938-42. PubMed ID: 15026327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours.
    Vorechovský I; Tingby O; Hartman M; Strömberg B; Nister M; Collins VP; Toftgård R
    Oncogene; 1997 Jul; 15(3):361-6. PubMed ID: 9233770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer.
    Ling G; Ahmadian A; Persson A; Undén AB; Afink G; Williams C; Uhlén M; Toftgård R; Lundeberg J; Pontén F
    Oncogene; 2001 Nov; 20(53):7770-8. PubMed ID: 11753655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that superficial basal cell carcinoma is monoclonal from analysis of the Ptch1 gene locus.
    Saldanha G; Shaw JA; Fletcher A
    Br J Dermatol; 2002 Nov; 147(5):931-5. PubMed ID: 12410703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
    van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC
    Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is human patched the gatekeeper of common skin cancers?
    Sidransky D
    Nat Genet; 1996 Sep; 14(1):7-8. PubMed ID: 8782809
    [No Abstract]   [Full Text] [Related]  

  • 33. Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32.
    Smyth I; Narang MA; Evans T; Heimann C; Nakamura Y; Chenevix-Trench G; Pietsch T; Wicking C; Wainwright BJ
    Hum Mol Genet; 1999 Feb; 8(2):291-7. PubMed ID: 9931336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introduction of wild-type patched gene suppresses the oncogenic potential of human squamous cell carcinoma cell lines including A431.
    Koike C; Mizutani T; Ito T; Shimizu Y; Yamamichi N; Kameda T; Michimukai E; Kitamura N; Okamoto T; Iba H
    Oncogene; 2002 Apr; 21(17):2670-8. PubMed ID: 11965540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High frequency of loss of heterozygosity on chromosome region 9p21-p22 but lack of p16INK4a/p19ARF mutations in greek patients with basal cell carcinoma of the skin.
    Saridaki Z; Koumantaki E; Liloglou T; Sourvinos G; Papadopoulos O; Zoras O; Spandidos DA
    J Invest Dermatol; 2000 Oct; 115(4):719-25. PubMed ID: 10998150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour suppressors. Dispatches from patched.
    Shilo BZ
    Nature; 1996 Jul; 382(6587):115-6. PubMed ID: 8700198
    [No Abstract]   [Full Text] [Related]  

  • 37. Preliminary mapping of the deleted region of chromosome 9 in bladder cancer.
    Cairns P; Shaw ME; Knowles MA
    Cancer Res; 1993 Mar; 53(6):1230-2. PubMed ID: 8443801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tracking the gatekeeper gene in the stages of carcinogenesis in the bladder].
    Baud E; Catilina P; Bignon YJ
    Bull Cancer; 1997 Oct; 84(10):971-5. PubMed ID: 9435799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors.
    Xie J; Johnson RL; Zhang X; Bare JW; Waldman FM; Cogen PH; Menon AG; Warren RS; Chen LC; Scott MP; Epstein EH
    Cancer Res; 1997 Jun; 57(12):2369-72. PubMed ID: 9192811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome.
    Aszterbaum M; Rothman A; Johnson RL; Fisher M; Xie J; Bonifas JM; Zhang X; Scott MP; Epstein EH
    J Invest Dermatol; 1998 Jun; 110(6):885-8. PubMed ID: 9620294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.